Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nitrous oxide free low-flow anesthesia].

J Baum1, B Sievert, H G Stanke

  • 1Abteilung für Anästhesie und Intensivmedizin, Krankenhaus St. Elisabeth-Stift, Damme. j.baum.damme@t-online.de

Anaesthesiologie Und Reanimation
|August 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis.

Psychological medicine·2024
Same author

Editorial: control of acid secretion.

Alimentary pharmacology & therapeutics·2018
Same author

Letter: vonoprazan, a long-lasting acid suppressor of the gastric H+, K+-ATPases with - implications for renal H+, K+-ATPases; authors' reply.

Alimentary pharmacology & therapeutics·2016
Same author

Corrigendum. The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase.

Alimentary pharmacology & therapeutics·2016
Same author

The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.

Alimentary pharmacology & therapeutics·2015
Same author

Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.

Alimentary pharmacology & therapeutics·2015
Same journal

The influence of Sir Robert Reynolds Macintosh on the development of anaesthesia.

Anaesthesiologie und Reanimation·2004
Same journal

[Anaesthesia for combined pancreatic and renal transplantation in a patient with mitochondrial encepahalomyopathy--a case report].

Anaesthesiologie und Reanimation·2004
Same journal

[What is anaesthesiology worth in the German DRGs?--First experience with German DRGs].

Anaesthesiologie und Reanimation·2004
Same journal

[Implantable drug pumps for spinal opioid analgesia: technical solutions and problems].

Anaesthesiologie und Reanimation·2004
Same journal

[Remifentanil analgesia for aspiration of follicles for oocyte retrieval].

Anaesthesiologie und Reanimation·2004
Same journal

[Paediatric anaesthesia: inhaled or intravenous technique?].

Anaesthesiologie und Reanimation·2004
See all related articles

Routine use of nitrous oxide in anesthesia is questioned. Eliminating it is feasible by adjusting opioid and anesthetic doses, simplifying low-flow techniques, and reducing costs and environmental impact.

Area of Science:

  • Anesthesiology
  • Respiratory Medicine
  • Pharmacology

Background:

  • Nitrous oxide (N2O) use as a routine carrier gas in anesthesia is increasingly questioned.
  • Surveys indicate N2O use is recommended only in specific cases, but precise indications are lacking.
  • Contraindications for N2O are numerous, yet clear guidelines for its justified use are absent.

Purpose of the Study:

  • To evaluate the feasibility and implications of performing inhalational anesthesia without nitrous oxide.
  • To determine if the analgesic and hypnotic effects of N2O can be compensated for by other anesthetic agents.
  • To assess the impact of eliminating N2O on low-flow anesthesia techniques and overall costs.

Main Methods:

  • Clinical practice evaluation of inhalational anesthesia without N2O.

Related Experiment Videos

  • Adjustment of opioid dosage to compensate for missing analgesic effects.
  • Modification of volatile anesthetic concentrations (isoflurane, sevoflurane, desflurane) to achieve hypnotic effects.
  • Implementation and assessment of low-flow and closed-system anesthesia techniques.
  • Cost-benefit analysis comparing N2O-free anesthesia with traditional methods.

    • Main Results:

    • Inhalational anesthesia can be performed without N2O by increasing opioid and volatile anesthetic doses.
    • Eliminating N2O facilitates low-flow anesthesia, reducing total gas uptake and simplifying nitrogen washout.
    • N2O-free anesthesia allows for tighter control of gas volumes in breathing systems, enabling closed-system techniques.
    • Cost analysis indicates that savings from eliminating N2O balance or outweigh increased costs of other agents and opioids.
    • Clinical trial involving over 1,800 patients demonstrated uncomplicated N2O-free anesthesia with manageable cost implications.

    Conclusions:

    • Routine use of nitrous oxide in anesthesia can be abandoned without compromising patient care.
    • Eliminating N2O simplifies low-flow anesthesia, improves gas economy, and potentially enhances patient safety.
    • N2O-free anesthesia is clinically feasible, cost-effective, and ecologically beneficial.
    • Further research should focus on refining indications for N2O and optimizing N2O-free anesthetic protocols.